Journalartikel

Infection and sepsis prevention in prostate biopsy


AutorenlisteWagenlehner, F. M. E.; Pilatz, A.; Waliszewski, P.; Dansranjavin, T.; Weidner, W.

Jahr der Veröffentlichung2013

Seiten1459-1466

ZeitschriftUrologe A

Bandnummer52

Heftnummer10

ISSN0340-2592

eISSN1433-0563

DOI Linkhttps://doi.org/10.1007/s00120-013-3284-4

VerlagSpringer


Abstract
Prostate biopsy is currently the gold standard in the diagnosis of carcinoma of the prostate. An estimated one million prostate biopsies are performed every year in Europe. Worldwide the most frequent form is the transrectal prostate biopsy using preoperative fluoroquinolone prophylaxis. In recent years an increasing rate of infectious complications after prostate biopsy has been observed. The main causative factor is fecal fluoroquinolone-resistant bacteria. This review aims to present the current evidence regarding infectious complications after prostate biopsy and strategies to reduce symptomatic infections and urosepsis.



Zitierstile

Harvard-ZitierstilWagenlehner, F., Pilatz, A., Waliszewski, P., Dansranjavin, T. and Weidner, W. (2013) Infection and sepsis prevention in prostate biopsy, Urologe A, 52(10), pp. 1459-1466. https://doi.org/10.1007/s00120-013-3284-4

APA-ZitierstilWagenlehner, F., Pilatz, A., Waliszewski, P., Dansranjavin, T., & Weidner, W. (2013). Infection and sepsis prevention in prostate biopsy. Urologe A. 52(10), 1459-1466. https://doi.org/10.1007/s00120-013-3284-4



Schlagwörter


BLOOD-STREAM INFECTIONCOMPLICATIONSInfectious complicationsPostoperative infectionsProstate biopsyProstate carcinomaUrosepsis


Nachhaltigkeitsbezüge


Zuletzt aktualisiert 2025-21-05 um 18:38